Published this month in Scientific Reports, the paper explains how stem cell growth can be stimulated in tooth pulp, using
a drug approved for Alzheimer's treatment.
«There is
no drug approved for treating heartworms in cats the reaction to the dead and dying worms can cause sudden death.»
Clomacalm, a veterinary
drug approved for canine separation anxiety, can also help cats with this problem.
The other leading
drug approved for restless legs syndrome, Mirapex, is still available as a brand name only.
Risperidone, the first
drug approved for children with autism and the most widely used, improves some behavior but can have severe side effects such as sleepiness and weight gain
Many stimulants are specifically marketed as antiobesity drugs, including phentermine and lisdexamfetamine dimesylate (Vyvanse), which earlier this year became the first
drug approved for the treatment of binge - eating disorder.
There is real satisfaction in knowing that one's work has, hopefully, helped to get
that drug approved for use in the general population.
Cindy Whitehead, the founder and COO of the Raleigh, North Carolina - based company, has been fighting to get
the drug approved for four years.
There are currently no vaccines or
drugs approved for human use and no post-exposure treatment that has completely protected nonhuman primates against MARV - Angola, the most deadly Marburg viral strain, with a mortality rate of up to 90 percent.
Risperidone is also one of the very few «atypical» antipsychotic
drugs approved for use in children.
An alternative approach to detect new antitumor compounds is the screening of
drugs approved for other indications for their efficacy against cancer cells.
As Motzer pointed out, those results are better than the results of phase 3 trials for the existing
drugs approved for the treatment of RCC.
â $ There are two
drugs approved for reducing your risk of getting breast cancer: raloxifene, which is approved for use in postmenopausal women, and tamoxifen, which is approved for all ages, â $ explains Dr. Gralow.
Due to lack of clinical studies and safe medications, there are
no drugs approved for use in feline heartworm infestations at this time.
As you work with your veterinarian to review management practices for avoiding milk and meat residues, the Milk and Dairy Beef Drug Residue Prevention manual from the National Milk Producers Federation also serves as a valuable educational tool and resource for
drugs approved for use in nonlactating and lactating dairy cattle.
The drugs approved for use in the US are ivermectin (sold under the brand names Heartgard, Iverhart, and several other generic versions), milbemycin (Interceptor Flavor Tabs and Sentinel Flavor Tabs) and moxidectin (ProHeart) administered as pills or chewable tablets.
Not exact matches
Stevia was
approved by the Food and
Drug Administration nearly six years ago, and since it comes from the leaves of a plant and has no calories, it has led the charge in the search
for more natural alternatives to sugar.
The key is to avoid a company that has only a few
drugs in the pipeline that one day may or may not be
approved for use by the FDA.
The endorsement came despite lingering questions about safety and effectiveness, but also followed a high - stakes pressure campaign in which the manufacturer accused the Food and
Drug Administration of gender bias, since several pills were already
approved for men with sexual problems.
But before his arrest, he said he'd use KaloBios as a vehicle to nab another niche
drug, this time
for treatment of the parasitic infection Chagas disease, and dramatically increase its price to the $ 60,000 to $ 100,000 range after helping it win FDA approval (the
drug is
approved in other countries and is provided to patients in the U.S. on a special and selective basis).
Dr. Nir Barzilai, the director of Institute
for Aging Research at the Albert Einstein College of Medicine in New York, has been researching the
drug, with the hopes of one day getting it
approved as an anti-aging treatment by the FDA.
The plan also calls
for generic versions of any
drug or treatment to be available as soon as the Food and Drug Administration approves
drug or treatment to be available as soon as the Food and
Drug Administration approves
Drug Administration
approves it.
Aurora Cannabis was up 2.5 % in early Wednesday trading; the U.K.'s GW Pharmaceuticals, which is vying
for the first Food and
Drug Administration (FDA)
approved cannabis - based medicine in the U.S., rose more than 2 %; Canada's MedReleaf spiked 4 % while Aprhia had a more modest 1 % rise.
The price is
for Spark Therapeutics» Luxturna,
approved by the Food and
Drug Administration in December to treat a rare, inherited retinal disease that can lead to blindness.
The memory - eating disease, expected to afflict 15 million Americans by 2060 (and tens of millions more around the world as life expectancy increases), has no cure; a new
drug for the condition hasn't been
approved in well over a decade; initially promising experimental treatments seem to be failing with clockwork regularity; and there's not even a definitive consensus on what, exactly, biopharma companies should focus on while developing Alzheimer's medicines.
For instance, just last month, the Food and Drug Administration (FDA) approved ViiV's Juluca, the first - ever treatment for HIV - 1 that contains just two drugs (rather than the three or more involved in most HIV therapy cocktail
For instance, just last month, the Food and
Drug Administration (FDA)
approved ViiV's Juluca, the first - ever treatment
for HIV - 1 that contains just two drugs (rather than the three or more involved in most HIV therapy cocktail
for HIV - 1 that contains just two
drugs (rather than the three or more involved in most HIV therapy cocktails).
Intarcia has completed several late - stage clinical trials in which it uses the pump to deliver a glucose - controlling
drug continuously
for months — an idea, that if successful (and
approved by the FDA) could significantly help patients with type 2 diabetes, fewer than half of whom maintain the recommended glycemic levels.
U.S. regulators this week
approved the first
drug for a new type of cancer treatment, confirming a theme some stock pickers have found in biotech.
Plus, a handful of companies will typically all get
approved to make a generic at once, which ideally creates competition in the marketplace and can sometimes result in even lower prices
for those
drugs.
She said the research bill would «legalize fraud» by reducing the scientific evidence the government needs to
approve existing
drugs for new uses.
Since then, the companies have been scrambling to rack up indications
for the rival
drugs, which are both
approved for treating melanoma and lung cancer.
The FDA and Flatiron Health have been collaborating to explore how the FDA might be able to use real - world data (that clinical information Flatiron collects) to inform how
drugs the agency
approves are used outside of the clinical trials that are the basis
for their approval.
Earlier this month, the FDA
approved two other treatments
for multiple myeloma, including another kind of monoclonal antibody
drug (the same class of
drug that elotuzumab is in).
Though hailed as «a new therapeutic principle» in 1990, it nonetheless took another eight years
for the FDA to
approve the first antisense
drug, fomivirsen —
for the treatment of AIDS - related retinitis caused by human cytomegalovirus.
Approved treatments included gene therapies and the first new
drugs for rare diseases in many years.
In March, the U.S. Food and
Drug Administration (FDA)
approved BLINCYTO
for the treatment of adults and children with B - cell precursor acute lymphoblastic leukemia in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1 percent.
While it's not
approved specifically
for anti-aging treatments, like other
drugs, it can be prescribed
for so - called off - label uses as long as there is no advertising or efficacy claims involved.
Merck and Bristol - Myers Squibb each have
approved immunotherapy
drugs, while Gilead Sciences announced Monday it plans to acquire Kite Pharma
for $ 11.9 billion, just a few months before the FDA is expected to
approve Kite's CAR - T
drug for lymphoma on Nov. 29.
On Wednesday, the U.S. Food and
Drug Administration approved Novartis» Kymriah, the first drug for a new kind of cancer treatment called CAR - T cell ther
Drug Administration
approved Novartis» Kymriah, the first
drug for a new kind of cancer treatment called CAR - T cell ther
drug for a new kind of cancer treatment called CAR - T cell therapy.
The FDA has called
for more user - friendly forms of the
drug — it
approved a nasal - spray version in November.
But the U.S. Food and
Drug Administration has not
approved any health claims
for probiotics.
BMS's
drug, ipilimumab (Yervoy), was the first checkpoint inhibitor (a kind of cancer immunotherapy
drug that essentially helps the immune system release its brake and go after tumor cells it might normally miss) to get
approved in the US in 2011
for melanoma.
For decades, naloxone, a
drug approved in 1971 that instantly reverses the effect of opioid overdose, languished in relative obscurity.
Approved by the FDA in 2011
for metastatic melanoma, Yervoy was the first
drug to offer a survival benefit to patients with that disease.
Dr. Chawla designed and led the ATHOS 3 Phase 3 trial
for La Jolla Pharmaceutical's FDA -
approved drug for shock, Giapreza ™.
Canadian online pharmacies have built a good reputation among American consumers
for selling U.S. -
approved drugs at a steep discount.
Vascepa has been
approved for use by the United States Food and
Drug Administration (FDA) as an adjunct to diet to reduce triglyceride levels in adult patients with severe (≥ 500 mg / dL) hypertriglyceridemia.
The new indication puts Kymriah in direct competition with Gilead Sciences» Yescarta, which was
approved by the U.S. Food and
Drug Administration in October
for treatment of adults with diffuse large B - cell lymphoma who have failed to respond to other treatments.
PCSK9 inhibitors, the main ingredients in Amgen's Repatha and Sanofi and Regeneron's Praluent treatments, were first
approved by the Food and
Drug Administration in July 2015
for use by patients with a family history of high cholesterol or those who suffered high - cholesterol - induced heart attacks.
If it works, it could be used in a far greater number of patients than Sarepta's
drug, which is
approved for a relatively small slice of the DMD patient pool.